{"id":772073,"title":"The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment, CCDR 47(12) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T16:16:27.053000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-12-december-2021/hepatitis-c-canada-surveillance-injection-drug-use-harm-reduction-treatment.html","snippet":"Surveillance trends of hepatitis C in Canada Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 47-12, December 2021: Social Media Responses to COVID-19 Date published: December 2021 ISSN: 1481-8531 Subscribe to CCDR Information for…","rawSnapshotUrl":"/api/snapshots/raw/772073","browseUrl":"https://replay.healtharchive.ca/job-7/20260306161627/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-12-december-2021/hepatitis-c-canada-surveillance-injection-drug-use-harm-reduction-treatment.html#ha_snapshot=772073","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}